Next, the correlation between LINC01574 levels and clinical characteristics was analyzed; we found that the expression of LINC01574 in T2, III, and NI/2 BC tumor tissues was remarkably higher than that in T1, I/II, and N0 BC tumor tissues, respectively (Figure 1(f)). Here, LINC01574 is linked to breast cancer.